Founded at the Abramson Cancer Center at the University of Pennsylvania
Alex Psihogios

Alex Psihogios, PhD

Attending Psychologist, Division of Oncology, CHOP

Assistant Professor, Departments of Psychiatry and Pediatrics, University of Pennsylvania Perelman School of Medicine

Alex Psihogios, PhD, is an Innovation Faculty member at the Penn Center for Cancer Care Innovation and a psychologist and behavioral scientist in the Division of Oncology at Children’s Hospital of Philadelphia. Dr. Psihogios’ research program is centered on improving health outcomes for adolescents and young adults (AYA) with cancer by targeting a modifiable health behavior —  medication adherence. Her research studies use state-of-the-art mobile health approaches to learn how to deliver adherence support in the moment and context that AYA need it the most, and how this information can be leveraged for personalized interventions. Dr. Psihogios is also interested in improving digital health implementation so that these tools can benefit patients in real-world care delivery settings.

 

Toward this goal, in 2019, Dr. Psihogios received a Mentored Clinical Scientist Research Career Development Award (K08) from the National Cancer Institute to translate ecological momentary assessment data into a just-in-time adaptive intervention for promoting oral chemotherapy adherence in AYA with leukemia.

 

In 2017, the American Cancer Society awarded her a postdoctoral grant to conduct a formative, mixed methods study of facilitators and barriers to AYA cancer treatment adherence. In 2018, the Mattie Miracle Cancer Foundation awarded Dr. Psihogios a pilot grant to test the feasibility and acceptability of using a hospital-based text messaging service to assess daily oral chemotherapy adherence in AYA with leukemia.

 

Among her notable career accomplishments, Dr. Psihogios: Received the Distinguished Research Trainee Award (Postdoctoral Fellow Category) from the Research Institute at Children’s Hospital of Philadelphia; Leads a NIH-funded study to develop the first just-in-time adaptive intervention for promoting oral chemotherapy adherence among AYA with acute lymphoblastic leukemia; Co-founded and co-chairs the Society of Pediatric Psychology Digital Health Special Interest Group (American Psychological Association, Division 54).

Related Publications